Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib as preemptive analgesic in therapeutic knee arthroscopy
2006-000451-17Phase 3Active
- Sponsor
- Marienkrankenhaus Soest
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of etoricoxib in disorders of knee, sponsored by Marienkrankenhaus Soest. Primary endpoint: Opioid reduction within 48 hours postoperatively. Started Oct 2006; status: active.
02
Drugs
etoricoxib
03
Conditions
disorders of knee
Beyond the preview
Go deeper on 2006-000451-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000451-17.